Qiagen Shares Rise on Reports of Potential €9.6 Billion Acquisition by EQT AB
Shares of Qiagen (QGEN) increased by 2% following reports that private equity firm EQT AB is nearing a deal to acquire the European molecular testing company. The proposed acquisition is valued at approximately €9.6 billion ($10.8 billion). According to reports, Qiagen's board of directors is reportedly close to approving the transaction. If finalized, this deal would represent a significant consolidation within the molecular diagnostics and life sciences sector.
Topics: M&A Molecular Testing Private Equity
Read the full article at Seeking Alpha
Part of the story Qiagen Shares Rise on Reports of Potential €9.6 Billion Acquisition by EQT AB (2 articles)